UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000007716 |
|---|---|
| Receipt number | R000009095 |
| Scientific Title | Efficacy of Linagliptin in Japanese type 2 diabetic patients in hemodialysis |
| Date of disclosure of the study information | 2012/04/10 |
| Last modified on | 2014/10/10 13:39:57 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy of Linagliptin in Japanese type 2 diabetic patients in hemodialysis
Acronym
Linagliptin T2D patients in hemodialysis
Scientific Title
Efficacy of Linagliptin in Japanese type 2 diabetic patients in hemodialysis
Scientific Title:Acronym
Linagliptin T2D patients in hemodialysis
Region
| Japan |
Condition
Condition
Japanese type 2 diabetic patients in hemodialysis
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To examine whether Linagliptin could improve glycemic control and decrease oxidative stress in type 2 diabetic patients in hemodialysis
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Exploratory
Trial characteristics_2
Pragmatic
Developmental phase
Not applicable
Assessment
Primary outcomes
glycated albumine
Key secondary outcomes
Nitrotyrosine
oxidized LDL
BNP
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Linagliptin5mg
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 85 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Japanese type 2 diabetic patients in hemodialysis
Key exclusion criteria
type 1 diabetic patients
insulin dependent diabetes mellitus
patients with antiGAD antiody
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Toshihiko Yanase |
Organization
Fukuoka University
Division name
Department of Endocrinology and Diabetes Mellitus
Zip code
Address
7-45-1 Nanakuma, Jonanan-ku, Fukuoka
TEL
092-801-1011
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Takashi Nomiyama |
Organization
Fukuoka University
Division name
Department of Endocrinology and Diabetes Mellitus
Zip code
Address
7-45-1 Nanakuma, Jonanan-ku, Fukuoka
TEL
092-801-1011
Homepage URL
tnomiyama@fukuoka-u.ac.jp
Sponsor or person
Institute
Fukuoka University hospital
Institute
Department
Personal name
Funding Source
Organization
Fukuoka University, department of endocrinology and diabetes mellitus
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
福岡大学病院
Other administrative information
Date of disclosure of the study information
| 2012 | Year | 04 | Month | 10 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2012 | Year | 03 | Month | 28 | Day |
Date of IRB
Anticipated trial start date
| 2012 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2012 | Year | 04 | Month | 10 | Day |
Last modified on
| 2014 | Year | 10 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000009095
